NCT03749187
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03749187
Title BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas (PNOC017)
Acronym PNOC017
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors University of California, San Francisco
Indications
Therapies
Age Groups: adult | child
Covered Countries USA

Facility Status City State Zip Country Details
Children's Hospital Los Angeles Los Angeles California 90027 United States Details
University of California, San Francisco San Francisco California 94143 United States Details
Yale University New Haven Connecticut 06520 United States Details
Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore Maryland 21287 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Washington University School of Medicine St Louis Missouri 63110 United States Details
Joseph M. Sanzari Children's Hospital at Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
Oregon Health and Science University Portland Oregon 97239 United States Details
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 United States Details
St. Jude Children's Research Hospital Memphis Tennessee 38105 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field